Exploring the Effectiveness of a Brief CBT Intervention for Anxious Pregnant Women
Launched by UNIVERSITY OF EDINBURGH · Mar 31, 2017
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
This study is a prospective matched cohort design with follow up. The treatment group will consist of women who attend once to a one off 3 hour brief cognitive behavioural therapy treatment (CBT) session. Outcome measures will be completed at 3 time points, baseline, 2 weeks post intervention and 2 weeks' post partum (follow up).
A previously published dataset collected locally will be used as a control group. This dataset includes 120 sets of data who have completed the Hospital Anxiety and Depression Scale (HADS) which will be the primary outcome measure for this study. Furthermore, the ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Pregnant woman
- • Referred to group and screened for suitability
- • Attended brief pregnancy session
- • Contact with community midwife
- • General anxiety (Score \>8 on HADS)
- • Able to read, write and understand English
- • Aged over 16
- • Ability to give consent
- Exclusion Criteria:
- • Exclusion criteria will include severe mental health problems such as severe depression with suicidal ideation, psychosis, personality disorder; terminal illness; inability to give informed consent in English, and inability to understand written and spoken English as questionnaires are not standardized in other languages.
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, Scotland, United Kingdom
Patients applied
Trial Officials
Paul Morris, Health Psychology
Study Chair
University of Edinburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials